HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Genetic study links higher LDL cholesterol causally to motor neurone disease risk

Louis Nervegna · Oct 15, 2025 · ♥ 8 reactions · 8 comments · original Facebook post
LDL, ApoB & lipid panelStatinsBrain health & dementia
AI summary & key facts

Louis shares a 2019 Queen Mary University of London press release on the largest genetic (causal) study of motor neurone disease/ALS risk factors, which found higher LDL cholesterol was causally linked to greater risk. The investigators suggest studying whether cholesterol-lowering drugs such as statins could protect against the disease.

Statins and other cholesterol lowering drugs might protect against motor neurone disease and ALS.

Quoted:

Dr Alastair Noyce from Queen Mary’s Wolfson Institute of Preventive Medicine said: “This is the largest study to-date looking at causal risk factors for motor neurone disease and we saw that higher levels of LDL cholesterol were causally linked with a greater risk of the disease.

“We have well-established drugs that can lower cholesterol and we should look into whether they could protect against this terrible disease, which currently has no cure.

“The next steps will include studying whether lowering levels of cholesterol might have a protective effect against MND, and potentially evaluating the use of cholesterol-modifying drugs in people at risk of MND.”

qmul.ac.ukStatins could protect against motor neurone diseaseqmul.ac.uk

#statinsHD #motorneuronediseaseHD #alsHD

Research cited

← newer: Centenarians' higher LDL reflects survivorship bias, not a bolder: Statin muscle side effects traced to HMG-CoA reductase gene →